Literature DB >> 27093794

[Comparison Study of Oropharyngeal Microbiota in Case of Bronchial Asthma and Chronic Obstructive Pulmonary Disease in Different Severity Levels].

L M Ogorodova, S V Fedosenko, A S Popenko, V A Petrov, A V Tyakht, I V Saltykova, I A Deev, E S Kulikov, N A Kirillova, V M Govorun, E S Kostryukova.   

Abstract

BACKGRAUND: The result of comparative study of oropharyngeal microbiota taxonomic composition in patients with different severity level of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) is presented in this paper. AIMS: To compare oropharyngeal microbiota composition in case of bronchial asthma and chronic obstructive pulmonary disease in different severity levels. METODS: 138 patients, 50 with BA and 88 with COPD were studied. For each patient was collected anamnesis vitae, swab from the back of the throat and performed physical examination. High-throughput 16S ribosomal RNA gene sequencing and bioinformatic analysis was employed to characterize the microbial communities.
RESULTS: As a result of the study wasfound a number of differences on various taxonomic levels in microbiota's composition within group of patients with different severity level of BA and group of patients with different severity level of COPD and between those groups. COPD patients with GOLD 1-2 in comparison with GOLD 3-4 patiens are marked by prevalence of species Brevibacterium aureum, genus Scardovia, Coprococcus, Haemophilus, Moryella, Dialister, Paludibacter and decrease of Prevotella melaninogenica species. BA patients with severe uncontrolled asthma in comparison with patients which have mild persistent asthma are marked by decrease of Prevotella and increase of species Bifidobacterium longum, Prevotella nanceiensis, Neisseria cinerea, Aggregatibacter segnis and genus Odoribacter, Alloiococcus, Lactobacillus, Megasphaera, Parvimonas, Sneathia. Patient's microbiota in BA group in comparison with COPD group is characterized by the prevalence of Prevotella melaninogenica and genus Selenomonas, Granulicatella u Gemella, and decrease of Prevotella nigrescens, Haemophilus influenza and genus Aggregatibacter, Alloiococcus, Catonella, Mycoplasma, Peptoniphilus u Sediminibacterium. There are no differences between microbiota composition in case of severe uncontrolled BA and very severe COPD.
CONCLUSION: Lack of differences in oropharyngeal microbiota taxonomic composition between patients with severe uncontrolled BA and very severe COPD allow us to suggest a similarity of bronchopulmonary system condition in case of diseases' severe stages.

Entities:  

Mesh:

Year:  2015        PMID: 27093794     DOI: 10.15690/vramn532

Source DB:  PubMed          Journal:  Vestn Ross Akad Med Nauk        ISSN: 0869-6047


  5 in total

1.  Characterization of throat microbial flora in smokers with or without COPD.

Authors:  Wenqi Diao; Ning Shen; Yipeng Du; Ke Qian; Bei He
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-04

2.  Oropharyngeal and Sputum Microbiomes Are Similar Following Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Hai-Yue Liu; Shi-Yu Zhang; Wan-Ying Yang; Xiao-Fang Su; Yan He; Hong-Wei Zhou; Jin Su
Journal:  Front Microbiol       Date:  2017-06-22       Impact factor: 5.640

Review 3.  The crosstalk between microbiome and asthma: Exploring associations and challenges.

Authors:  Mahmoud I Abdel-Aziz; Susanne J H Vijverberg; Anne H Neerincx; Aletta D Kraneveld; Anke H Maitland-van der Zee
Journal:  Clin Exp Allergy       Date:  2019-06-27       Impact factor: 5.018

4.  Microbiological characteristics of different tongue coatings in adults.

Authors:  Caihong He; Qiaoyun Liao; Peng Fu; Jinyou Li; Xinxiu Zhao; Qin Zhang; Qifeng Gui
Journal:  BMC Microbiol       Date:  2022-09-09       Impact factor: 4.465

5.  Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.

Authors:  Wenqi Diao; Ning Shen; Yipeng Du; John R Erb-Downward; Xiaoyan Sun; Chenxia Guo; Qian Ke; Gary B Huffnagle; Margaret R Gyetko; Bei He
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.